2024
WHO Collaborating Centre for Pharmaceutical Pricing and Reimbursement Policies. Abstract Poster Book. 5th PPRI conference 2024: Ensuring access to affordable medicines through innovative policies, Vienna, 25–26 April 2024. Vienna: Gesundheit Österreich, 2024
Zimmermann N, Schneider P, Paknutova S, Piniazhko O. Evaluation of the external price referencing (EPR) policy for the National Essential Medicines List in Ukraine. 5th PPRI conference 2024: Ensuring access to affordable medicines through innovative policies, Vienna, 25–26 April 2024
Vogler S, Salcher-Konrad M, Knoll V. Community pharmacy in Austria, England, Estonia and Portugal: Has the COVID-19 pandemic changed the range of pharmacy services offered? 5th PPRI conference 2024: Ensuring access to affordable medicines through innovative policies, Vienna, 25–26 April 2024
Salcher-Konrad M, Stefan F, Knoll V, Vogler S. Pharmaceutical care in Austria: A survey on services provided by community pharmacies. 5th PPRI conference 2024: Ensuring access to affordable medicines through innovative policies, Vienna, 25–26 April 2024
Vogler S, Zimmermann N, Haasis MA, Gombocz M, Knoll V. Approaching two decades of information sharing between competent authorities: Experience from the Pharmaceutical Pricing and Reimbursement Information (PPRI) network. 5th PPRI conference 2024: Ensuring access to affordable medicines through innovative policies, Vienna, 25–26 April 2024
Vogler S. Increasing prices to ensure availability of medicines? Financial incentives implemented as shortage mitigation policy in PPRI member countries. 5th PPRI conference 2024: Ensuring access to affordable medicines through innovative policies, Vienna, 25–26 April 2024
Knoll V, Steigenberger C, Fischer S, Vogler S. Made in Europe - assessing the feasibility of reshoring active pharmaceutical ingredient (API) production to Europe. 5th PPRI conference 2024: Ensuring access to affordable medicines through innovative policies, Vienna, 25–26 April 2024
Leopold C, Vogler S, Suleman F, Wirtz V. Strengthening primary health care through a stronger emphasis on patient and community centered medicines and pharmaceutical services. 5th PPRI conference 2024: Ensuring access to affordable medicines through innovative policies, Vienna, 25–26 April 2024
Salcher-Konrad M, Hendrickx A, Schneider P, Zimmermann N. Defining fair prices for new health technologies. 5th PPRI conference 2024: Ensuring access to affordable medicines through innovative policies, Vienna, 25–26 April 2024
2023
Fischer S, Schneider P, Habl C, Heindl B: Does pharmaceutical industry trick us? A price comparison of Infliximab across European countries. EUPHA-Conference. November 2023.
Steigenberger C, Windisch F, Vogler S: Barriers and Facilitators for the Use of Point of Care Diagnostics in Patients With Respiratory Tract Infections in Outpatient Care Related to the Peri-Launch Phase. ISPOR Europe 2023, Copenhagen, 12-15 November 2023.
Vogler S, Steigenberger C: Fit for Purpose Policy Recommendations Related to Funding, Pricing, and Procurement of Point-of-Care Tests Used in Patients With Respiratory Tract Infections. ISPOR Europe 2023, Copenhagen, 12-15 November 2023.
Schneider P, Salcher-Konrad M, Fischer S, Heindl B, Habl C: Bio-hybrid medicinal products – Widening access or product differentiation? ISPOR Europe 2023, Copenhagen, 14 November 2023
Salcher-Konrad M, Zimmermann N, Schneider P, Hendrickx A: What is a fair price? A review of definitions for fair prices of health technologies. ISPOR Europe 2023, Copenhagen, 14 November 2023
Windisch F, Vogler S: Medical Devices Glossary. Abbreviations, Terms, and Symbols. EuroDURG 2023. Bologna, 27 June 2023
2022
Vogler S, Zimmermann N: Design of value-added tax on medicines in 41 European countries. European Public Health (EPH) conference, Berlin, 9-12 November 2022
Salcher-Konrad M, Habimana K, Vogler S: Public Procurement of Medicines: A Taxonomy of Procurement Systems in Europe. ISPOR Europe 2022, Vienna, 9 November 2022
Zimmermann N, Vogler S, Haasis MA: Meta-Indicators for Analysing Pharmaceutical Systems: The PPRI Indicators. ISPOR Europe 2022, Vienna, 9 November 2022
2018
Vogler S, Österle A, Mayer S.: Towards more equitable medicine use?Developments in socio-economic determinants of the consumption of prescribed and non-prescribed medicines in Austria. Poster at the European Health Economics Association (EuHEA) conference, 11-14 July in Maastricht (NL), 2018
Haasis M, Dedet G, Lam J, Bak Pedersen H, Vogler S.: Reimbursement policies for out-patient medicines in countries of the WHO European Region: which practices best protect vulnerable groups?. Poster at the European Health Economics Association (EuHEA) conference, 11-14 July in Maastricht (NL), 2018
2016
Vogler S, Schneider P, Zimmermann N.: European price comparison of high-cost hospital medicines. Poster at the European Association of Hospital Pharmacists (EAHP) Congress in Vienna, 2016, Vienna
2015
PPRI: 10 years of PPRI. Poster at the 3rd PPRI Conference on 12/13 October in Vienna, 2015
WHOCC: Trainings and Workshops. Impressions of the trainings and workshops offered by the WHO Collaborating Centre for Pharmaceutical Pricing and Reimbursement Policies in Vienna, 2015
2014
Vogler S, Bak Pedersen H, de Joncheere K.: Price comparison of oncology medicines in 16 European countries. Poster at the Eurodurg Conference, 2014
Vogler S, Kilpatrick K, Babar Z-U-D.: Analysis of medicine prices in New Zealand and 16 European countries. Poster at the Eurodurg Conference, 2014
2013
Vogler S, Zimmermann N, Habl C, Leopold C, Habimana K, Mantel-Teeuwisse A, Dolinar E.: Which notions are applied to describe the cooperation mechanisms between hospital sector and primary care? Analysis of terminology. Poster at the EAHP (European Association of Hospital Pharmacists) Congress, 2013, Paris
Vogler S, Zimmermann N, Habl C, Leopold C, Dolinar E. : Survey about interface management measures regarding medication. Poster at the EAHP (European Association of Hospital Pharmacists) Congress, 2013, Paris
2011
Vogler S, Mazag J, Leopold C, Zimmermann N.: Generics promotion – analyzing differences between the hospital and out-patient sectors. Poster at the European Association of Hospital Pharmacists (EAHP) Congress in Vienna, 2011
Vogler S, Zimmermann N, Leopold C, Habl C, Mazag J.: Are hospital medicines prices influenced by discounts and rebates?. Poster at the International Society for Pharmacoeconomics and Outcomes Research (ISPOR) Congress in Madrid, 2011
Vogler S, Zimmermann N, Leopold C, Schmickl B, Windisch F.: Cost-containment measures on medicines prices in European countries during a global financial crisis year. Poster at the Pharmaceutical Pricing and Reimbursement Information (PPRI) Conference, 2011, Vienna
Vogler S, Zimmermann N, Leopold C, Schmickl B, Windisch F.: Impact of medicines price reductions in Greece and Spain on other European countries applying external price referencing. Poster at the Pharmaceutical Pricing and Reimbursement Information (PPRI) Conference, 2011, Vienna
Vogler S.: WHO Collaborating Centre for Pricing and Reimbursement Policies. Poster at the Pharmaceutical Pricing and Reimbursement Information (PPRI) Conference, 2011, Vienna
Vogler S, Habl C, Leopold C, Zimmermann N.: Role of Tendering of Medicines in European Countries. Poster at the International Conferences on Improving Use of Medicines (ICIUM) Conference, 2011
Vogler S, Habl C, Leopold C, Mazag J, Zimmermann N.: Prices of Medicines, Including High-Cost Cancer Medicines, in a Hospital Setting Compared to Outpatient Use. Poster at the International Conferences on Improving Use of Medicines (ICIUM) Conference, 2011
Vogler S, Habl C, de Joncheere K, Leopold C, Zimmermann N.: Policy Making Support by Sharing of Information and Experiences among the PPRI Network. Poster at the International Conferences on Improving Use of Medicines (ICIUM) Conference, 2011
Zimmermann N, Habl C, Schmickl B, Vogler S.: Perspectives of Rational Use of Medicines in the EU. Poster at the International Conferences on Improving Use of Medicines (ICIUM) Conference, 2011
Vogler S, Zimmermann N, Leopold C, Habl C, Mazag J.: Are hospital medicines prices influenced by discounts and rebates?. Poster at the Drug Utilisation and Health Policy Meeting organised by EuroDURG, 2011
Vogler S, Zuidberg C, Leopold C.: Analysis of medical waste in Vienna. Poster at the Drug Utilisation and Health Policy Meeting organised by EuroDURG, 2011
Vogler S, Zimmermann N, Leopold C, Schmickl B, Windisch F.: Impact of medicines price reductions in Greece and Spain on other European countries applying external price referencing. Poster at the Drug Utilisation and Health Policy Meeting organised by EuroDURG, 2011
2010
Vogler S, Mazag J, Leopold C, Zimmermann N.: PHIS Hospital Pharma. Poster at the Geneva Health Forum , 2010